. Author manuscript; available in PMC: 2020 Sep 11.

Published in final edited form as: Am J Phys Med Rehabil. 2020 Sep;99(9):795–800. doi: 10.1097/PHM.0000000000001411

Table 2.

Results of clinical tests for healthy subjects, mild ataxic and more severe ataxic subjects.

	Average Healthy Controls Score (SD)	Average Mild Ataxia Score (SD)	Average Severe Ataxia Score (SD)	Difference between mild and severe ataxia averages (95% CI)	P-Value	Effect Size
BBT Dominant	77.7 (10.7)	42.1 (7.1)	27.4 (10.9)	14.7 (4.0 to 25.4)	.01	.80
BBT Non-Dominant	74.3 (9.9)	40.0 (9.5)	26.6 (10.9)	13.4 (1.5 to 25.3)	.03	.66
9HPT Dominant in seconds	17.4 (1.7)	25.7 (2.4)	62.4 (30.5)	36.7 (11.5 to 61.9)	<.01	.85
9HPT Non-Dominant in seconds	18.9 (2.3)	34.0 (5.4)	71.3 (61.7)	37.3 (−13.7 to 88.3)	.14	.43
JTHFT Dominant in seconds	39.3 (1.6)	41.2 (9.0)	71.2 (33.5)	30.0 (1.4 to 58.6)	.04	.61
JTHFT Non-Dominant in seconds	41.7 (1.5)	55.1 (12.1)	82.5 (42.6)	27.4 (−9.1 to 63.9)	.13	.44

SD: standard deviation; 95% CI: 95% confidence interval; BBT: Box and Block Test; 9HPT: Nine Hole Peg Test; JTHFT: Jebsen Taylor Hand Function Test.